SEC Form 4 · accession 0001562180-17-003857
HP INC · HPQ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kim M Rivera
Officer — Chief Legal Officer, GC & Sec
Period of report
Dec 9, 2017
Accepted (ET)
Dec 12, 2017 · 5:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000047217
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 9, 2017 | M | 30,608 | $0.00 | A | 79,553 | D | |
| Common Stock | Dec 9, 2017 | F | 15,973 | $21.07 | D | 63,580 | D | |
| Common StockF2,F3 | Dec 12, 2017 | S | 14,635 | $21.0767 | D | 48,945 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF4,F1 | — | Dec 9, 2017 | M | 30,608 | D | — | — | Common Stock | 30,608 | 28,627 | D |
Explanation of responses
- F1Each Restricted Stock Unit ("RSU"') represents a contingent right to receive one share of HP common stock.
- F2The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/30/2016.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.99-$21.18, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4On 12/9/2015, the reporting person was granted 85,879 RSUs, 28,626 of which vested on 12/9/2016, 28,626 of which vested on 12/9/2017 and 28,627 of which are scheduled to vest 12/9/2018. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,982 vested dividend equivalent rights.